People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Palatin Technologies Inc | — | Pharmaceuticals | Series B | $35.0M | $1.2B | 2012 |
Robert K. deVeer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert K. deVeer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John K. A. Prendergast | 1 | 2 |
| Alan W. Dunton | 1 | 2 |
| Stephen T. Wills | 1 | 2 |
| Zola P. Horovitz | 1 | 2 |
| Carl Spana | 1 | 1 |
| Robert I. Taber | 1 | 1 |
| Perry B. Molinoff | 1 | 1 |
| Joseph Stanley Hull | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.